Lisondra, Novelyn .

HRN: 22-13-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2023
11/27/2023
IV
70mg
Q8H
Sepsis
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: